Express News | Aveanna Healthcare - Unknown Actor May Have Gained Unauthorized Access to Email Environment on September 25, 2023
Express News | Aveanna Healthcare: To Date, Is Not Aware of Any Evidence of Misuse of Any Information Potentially Involved in Incident
Aveanna Healthcare Notifies Individuals of Data Security Incident
Aveanna Healthcare ("Aveanna") has learned of a data security incident that may have impacted data belonging to certain employees and patients. On...
The Return Trends At Aveanna Healthcare Holdings (NASDAQ:AVAH) Look Promising
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding
Express News | Aveanna Healthcare Holdings, Inc. - Fourth Amendment Guaranty Facility increases the maximum available amount to $225 million.
Express News | On May 31st, Aveanna Healthcare Holdings Inc's unit signed the fourth amendment to the accounts receivable financing agreement with banks.
Express News | Aveanna Healthcare Holdings Inc - Fourth Amendment Amended Securitization Facility to Increase the Maximum Amount Available to $225.0 Million
Express News | Aveanna Healthcare Holdings Inc - on May 31, Co's Units Entered Into Fourth Amendment to Loan Parties' Receivables Financing Agreement With a Bank
Aveanna Healthcare Enhances Investor Communication With Presentation
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Held Back By Insufficient Growth Even After Shares Climb 27%
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) shareholders would be excited to see that the share price has had a great month, posting a 27% gain and recovering from prior weakness. The annual gai
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference
ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (NASDAQ:AVAH) today announced that its management team will attend the UBS Healthcare Services Cape Cod Summit in Chatham, MA on
UBS Adjusts Aveanna Healthcare Price Target to $1.70 From $1.60, Maintains Sell Rating
Aveanna Healthcare Holdings (AVAH) has an average rating of Hold and price targets ranging from $1.70 to $3, according to analysts polled by Capital IQ. Price: 2.44, Change: -0.06, Percent Change: -2.
Analysts' Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (ONCY), Aveanna Healthcare Holdings (AVAH) and Sanofi (OtherSNYNF)
Analyst Estimates: Here's What Brokers Think Of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) After Its First-Quarter Report
Earnings Call Summary | Aveanna Healthcare(AVAH.US) Q1 2024 Earnings Conference
The following is a summary of the Aveanna Healthcare Holdings Inc. (AVAH) Q1 2024 Earnings Call Transcript:Financial Performance:Aveanna Healthcare reported Q1 2024 revenue of $491 million, a 5.2% inc
Aveanna Healthcare Holdings Inc (AVAH) Q1 2024 Earnings: Revenue Rises, Losses Narrow
Aveanna Healthcare Engages Investors With Online Presentation
Aveanna Healthcare Holdings First Quarter 2024 Earnings: Beats Expectations
Truist Financial Sticks to Their Hold Rating for Aveanna Healthcare Holdings (AVAH)
Aveanna Healthcare: Prior Guidance for FY Was Rev of Between $1.96B and $1.98B >AVAH
Aveanna Healthcare: Prior Guidance for FY Was Rev of Between $1.96B and $1.98B >AVAH